Senior insider sale
Chief Operating Officer at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.61M
22.68K shares
NEERVANNAN SESHADRI plans to sell 22.68K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $1.61M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/18/2026 | Restricted Stock Vesting Compensation | 809.00 | — |
3/17/2026 | Restricted Stock Vesting Compensation | 1.09K | — |
3/16/2026 | Restricted Stock Vesting Compensation | 1.09K | — |
| Total | 2.99K | ||
Completed
Units to sell
4.59K
Market value
$307.5K
Units to sell
3.61K
Market value
$248.0K
Units to sell
3.13K
Market value
$216.9K
Units to sell
8.37K
Market value
$641.4K
Planned — Approximate Date
Units to sell
2.99K
Market value
$199.5K
Units
22.68K
Value
$1.61M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/19/2026 | 4.59K | $307.5K | — | Completed |
3/18/2026 | 3.61K | $248.0K | — | Completed |
3/17/2026 | 3.13K | $216.9K | — | Completed |
3/4/2026 | 8.37K | $641.4K | — | Completed |
| Planned — Approximate Date | ||||
3/20/2026 | 2.99K | $199.5K | NASDAQ | Planned |
| Total | 22.68K | $1.61M | ||